Heart drug may stop common complication after esophageal cancer surgery
NCT ID NCT06067438
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times
Summary
This study tests whether the heart medication amiodarone can prevent atrial fibrillation (an irregular, often rapid heartbeat) in people recovering from minimally invasive esophageal cancer surgery. Atrial fibrillation is the most common complication after this surgery, and there is no standard preventive treatment. The trial will randomly assign 90 participants to receive amiodarone or not, and track who develops the heart rhythm problem within seven days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
OHSU Knight Cancer Institute
RECRUITINGPortland, Oregon, 97239, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.